JPWO2021204896A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021204896A5
JPWO2021204896A5 JP2022561072A JP2022561072A JPWO2021204896A5 JP WO2021204896 A5 JPWO2021204896 A5 JP WO2021204896A5 JP 2022561072 A JP2022561072 A JP 2022561072A JP 2022561072 A JP2022561072 A JP 2022561072A JP WO2021204896 A5 JPWO2021204896 A5 JP WO2021204896A5
Authority
JP
Japan
Prior art keywords
oxo
benzenacyclotetradecaphan
diazepan
dimethoxy
dioxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022561072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521351A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/059096 external-priority patent/WO2021204896A1/en
Publication of JP2023521351A publication Critical patent/JP2023521351A/ja
Publication of JPWO2021204896A5 publication Critical patent/JPWO2021204896A5/ja
Pending legal-status Critical Current

Links

JP2022561072A 2020-04-07 2021-04-07 がんの治療のためのent阻害剤としての大環状ジアミン誘導体、及びそれとアデノシン受容体拮抗薬との組合せ Pending JP2023521351A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063006629P 2020-04-07 2020-04-07
US63/006,629 2020-04-07
PCT/EP2021/059096 WO2021204896A1 (en) 2020-04-07 2021-04-07 Macrocyclic diamine derivatives as ent inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists

Publications (2)

Publication Number Publication Date
JP2023521351A JP2023521351A (ja) 2023-05-24
JPWO2021204896A5 true JPWO2021204896A5 (pt) 2024-04-17

Family

ID=75441913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561072A Pending JP2023521351A (ja) 2020-04-07 2021-04-07 がんの治療のためのent阻害剤としての大環状ジアミン誘導体、及びそれとアデノシン受容体拮抗薬との組合せ

Country Status (14)

Country Link
US (1) US20230203058A1 (pt)
EP (1) EP4132933A1 (pt)
JP (1) JP2023521351A (pt)
KR (1) KR20230007369A (pt)
CN (2) CN116535365A (pt)
AR (1) AR121777A1 (pt)
AU (1) AU2021253634A1 (pt)
BR (1) BR112022020324A2 (pt)
CA (1) CA3179526A1 (pt)
CL (1) CL2022002772A1 (pt)
IL (1) IL297127A (pt)
MX (1) MX2022012558A (pt)
TW (1) TW202204365A (pt)
WO (1) WO2021204896A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059739A1 (en) * 2021-10-06 2023-04-13 iTeos Belgium SA Macrocyclic compounds having ent1 inhibiting activity
CN118076609A (zh) * 2021-10-06 2024-05-24 Iteos比利时公司 制备具有ent1抑制活性的大环化合物的方法
WO2023235464A1 (en) * 2022-06-01 2023-12-07 Duke University Novel equilibrative nucleoside transporter inhibitors and methods of making and using same
CN115417766B (zh) * 2022-08-31 2024-05-17 天津药明康德新药开发有限公司 一种3-羟基-4,5二甲氧基苯甲酸叔丁酯的合成方法
CN115650936A (zh) * 2022-10-26 2023-01-31 天津药明康德新药开发有限公司 一种(叔丁基(3)-1,4-二氮杂卓-1-丙基)氨基甲酸酯的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0906579D0 (en) 2009-04-16 2009-05-20 Vernalis R&D Ltd Pharmaceuticals, compositions and methods of making and using the same
CN102869631B (zh) 2010-02-08 2016-09-07 埃西勒国际通用光学公司 包含具有防雾性能的抗反射涂层的光学制品
ES2365960B1 (es) 2010-03-31 2012-06-04 Palobiofarma, S.L Nuevos antagonistas de los receptores de adenosina.
CN108697701B (zh) * 2016-02-04 2021-10-26 约翰霍普金斯大学 平衡型核苷转运蛋白1的抑制剂Rapadocin及其用途
UA126863C2 (uk) 2017-01-20 2023-02-15 Аркус Байосайєнсіз, Інк. Азолопіримідини для лікування ракових захворювань
TWI801372B (zh) 2017-03-30 2023-05-11 比利時商艾特歐斯比利時有限公司 作為a2a抑制劑的硫胺甲酸酯衍生物以及用於癌症治療的方法

Similar Documents

Publication Publication Date Title
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP7033079B2 (ja) 芳香族スルホンアミド誘導体
JP2020519589A5 (pt)
CN103096718B (zh) 可溶性鸟苷酸环化酶活化剂
RU2019120990A (ru) Бициклические гетероарильные производные в качестве стимуляторов cftr
AU6220401A (en) Imidazopyrimidine derivatives and triazolopyrimidine derivatives
JP2018530571A5 (pt)
JP2014525444A5 (pt)
TWI648272B (zh) 經取代之四氫咔唑及咔唑甲醯胺化合物
US10023576B2 (en) Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
JP2018524331A5 (pt)
JP2010502615A (ja) 5−リポキシゲナーゼ活性化タンパク質(flap)の阻害剤
CN105254634A (zh) 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物
JP2020516671A5 (pt)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2013531070A5 (pt)
KR20150027922A (ko) 신규한 항진균성 피리디닐하이드라자이드 유도체
JPH0517454A (ja) α−アリール−4−(4,5−ジヒドロ−3,5−ジオキソ−1,2,4−トリアジン−2(3H)−イル)−ベンゼンアセトニトリル誘導体
JPH0725864A (ja) 化学療法剤としての1,2,4−ジチアゾリウム塩類の使用
JPWO2021204896A5 (pt)
KR20100017745A (ko) Pde4 억제제로서 피라졸론 유도체
JP5980318B2 (ja) 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体
JPWO2020216764A5 (pt)